PA HB 672
in committeeAn Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, providing for coverage of allergenic protein dietary supplements.
Pennsylvania · 2025-2026 Regular Session (209th General Assembly) · lower
Quick answers
Did PA HB 672 pass?
Not yet. PA HB 672 is in committee as of 2025-02-20 and has not come to a final vote. Latest recorded action (2025-02-20): Referred to Insurance
What is PA HB 672 about?
PA HB 672 is a bill in the 2025-2026 Regular Session (209th General Assembly) titled “An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, providing for coverage of allergenic protein dietary supplements.”.
Who sponsors PA HB 672?
Gina Curry is the primary sponsor of PA HB 672, joined by 10 cosponsors.
- Introduced
- —
- Latest action
- 2025-02-20 — Referred to Insurance
- Bill type
- bill
- Last updated
- —
Sponsors
- Gina Curryprimary
- Tarah Probstcosponsor
- Maureen Maddencosponsor
- Nancy Guenstcosponsor
- Jose Giralcosponsor
- Benjamin Sanchezcosponsor
- Chris Piellicosponsor
- Jennifer O'Maracosponsor
- Malcolm Kenyattacosponsor
- Robert Freemancosponsor
- Danielle Friel Ottencosponsor
Committees
Not provided by source.
Action timeline
2025-02-20
Referred to Insurance
referral-committee
Versions
- Printer's No. PN0679Compare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:31:13.705233Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=PA&identifier=HB 672. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.